Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 32.64B P/E 37.97 EPS this Y 18.10% Ern Qtrly Grth 27.20%
Income 1.02B Forward P/E 30.02 EPS next Y 9.80% 50D Avg Chg 2.00%
Sales 4.69B PEG 1.78 EPS past 5Y 14.14% 200D Avg Chg 1.00%
Dividend 1.00% Price/Book 8.30 EPS next 5Y 14.70% 52W High Chg -10.00%
Recommedations 2.30 Quick Ratio 1.18 Shares Outstanding 146.93M 52W Low Chg 10.00%
Insider Own 0.80% ROA 12.70% Shares Float 145.62M Beta 0.69
Inst Own 60.12% ROE 22.70% Shares Shorted/Prior 8.58M/9.78M Price 222.15
Gross Margin 57.38% Profit Margin 21.79% Avg. Volume 639,504 Target Price 237.93
Oper. Margin 31.17% Earnings Date Oct 24 Volume 584,548 Change -1.42%
About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

ResMed Inc. News
09:40 AM This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
08:48 AM HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
11/20/24 3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
11/20/24 Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
11/20/24 Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
11/20/24 ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System
11/19/24 BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
11/18/24 ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
11/18/24 ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders
11/15/24 Here's Why You Should Add RMD Stock to Your Portfolio Now
11/15/24 Nevro Stock May Gain on the CE Mark Certification for HFX iQ
11/14/24 Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock
11/14/24 MYGN Stock Might Gain From SneakPeek Availability in Retail Stores
11/14/24 Insiders At ResMed Sold US$16m In Stock, Alluding To Potential Weakness
11/13/24 QGEN Collaborates With McGill University Centre: Stock to Gain?
11/13/24 Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours
11/11/24 INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
11/11/24 ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues
11/11/24 Zacks.com featured highlights include Greenbrier, Walmart, Leidos, InterDigital and ResMed
11/08/24 OPK Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts
RMD Chatroom

User Image swingingtech Posted - 1 day ago

$ZBH $HAE $GMED $RMD https://wallstreetwaves.com/zbh-stock-rises-following-ce-mark-approval-for-persona-revision-knee-system/

User Image Addictz1983 Posted - 1 week ago

$ZETA $BTCS $RMD Just Fyi.. ELAB is taking off. Add it to your watch list. Thanks!

User Image Monkey_Banana_Genius Posted - 1 week ago

$RMD when they going to buy $INSP? Long the latter.

User Image Winning_calls Posted - 1 week ago

$RMD pick me up @$253✌️

User Image insiderbuyingselling Posted - 1 week ago

$RMD new insider selling: 2000 shares. http://insiderbuyingselling.com/?t=RMD

User Image insiderbuyingselling Posted - 2 weeks ago

$RMD new insider selling: 69 shares. http://insiderbuyingselling.com/?t=RMD

User Image FilingFact Posted - 10/28/24

New financial insights available on https://www.filingfact.com/ from Fridays report of $RMD With the launch of the new platform we are offering 1 month of FREE Premium Access (worth $49) to the first 100 users! 🥳 💬 We’d love to hear your thoughts—your feedback will help us improving our service to your needs! For any questions, ideas, or support, reach out to us at [email protected] 👉 Join today and be a part of the journey!

User Image ivanhoff Posted - 10/27/24

Momentum Monday - TSLA Shines in a Volatile Tape https://ivanhoff.com/2024/10/27/tsla-shines-in-a-volatile-tape/ @MarketSurge @howardlindzon $TSLA $RMD $DECK $NFLX

User Image contangoz Posted - 10/25/24

CHART of day $rmd

User Image howardlindzon Posted - 10/25/24

$RMD sleep trend Is back... @Doozio wanted me to buy back In at $190. bad on me

User Image healthcareguru Posted - 10/25/24

$RMD time for the rug pull on this PoS…did everyone forget they’re scamming the government / Medicare? That’s why the DOJ is investigating them constantly… not worth more than $200. 👎 $XLV $SPY $IHI

User Image healthcareguru Posted - 10/25/24

$RMD short this dumb squeeze…next catalyst is the $LLY GLP-1 OSA FDA approval - that will tank this turd….easy short from here. HFs were waiting to get past the qtr to hammer this…we’ve got a bleeder. 👎 $XLV $IHI $SPY

User Image Miboom Posted - 10/25/24

$RMD Really well done you ResMedians in the world! Great numbers that you keep giving us, but also fantastic work to help many people get a good night's sleep

User Image RockyTSTH Posted - 10/25/24

$RMD looks that one big call won. stock up 7.3% almost reaching the expected 9% move

User Image 1986iamwallstreet Posted - 10/25/24

$RMD sell off @ the open …….

User Image motercycle Posted - 10/24/24

$MGRC great earnings, believe in $200+ long term $BYD I particularly love the online revenues versus the 5 year estimates. This possibly sees 75$ this quarter $SAG new ipo, I like the charts on this and the public offering being closed after just 2 trading days. $RMD Revenue is up by 1.12 billion, the last 4 quarters, the stock has only positively surprised the consensus. I see $275 this quarter $DECK great earnings all around, nothing much to complain about here, surpassing all estimates, there’s nothing much you can do better as a company, 200$ short term, 400$+ in 5 years

User Image InLongtoRetire Posted - 10/24/24

$RMSL ResMed ($RMD) Surpasses Q1 Earnings and Revenue Estimates Just wait until they get the opportunity to take on DeltaWave and future masks superior to anything on the market.

User Image NotHalfFast Posted - 10/24/24

$RMD well done ReMedians. Bear case blasted again. GLP-1 and smart phone diagnostic capabilities are powerful tailwinds. DD growth in all products and all geos. And new mask tech is going to be a “game changer” per MF. 👏👏

User Image InLongtoRetire Posted - 10/24/24

$RMD First Quarter 2025 Highlights All comparisons are to the prior year period Revenue increased by 11% to $1.2 billion; up 11% on a constant currency basis Gross margin improved 420 bps to 58.6%; non-GAAP gross margin improved 320 bps to 59.2% Income from operations increased 34%; non-GAAP income from operations up 27% Operating cash flow of $326 million Diluted earnings per share of $2.11; non-GAAP diluted earnings per share of $2.20

User Image cubie Posted - 10/24/24

@hamster60 OK hammy, $deck pop $rmd pop $ensg down so add 0 for 3 to ur 2 for 5 in last week and ur earnings gamble success rate dropped from 40% to 25% now. cubie follow! to do inverse of Hammy!🙈😅🙈🙊

User Image ShaleIntel Posted - 10/24/24

$RMD buying on consumer wearable technology.

User Image DonCorleone77 Posted - 10/24/24

$RMD ResMed reports Q1 non-GAAP EPS $2.20, consensus $2.04 Reports Q1 revenue $1.2B, consensus $1.18B. "Our first-quarter fiscal year 2025 results reflect ongoing momentum and strong execution across all areas of our business," said Mick Farrell, CEO of ResMed. "We delivered 11% year-over-year revenue growth, and our focus on operational excellence resulted in another quarter of year-over-year margin expansion and a 34% increase in operating profit. As we celebrate 35 years of growth and innovation, our recently launched 2030 strategy will further enable us to transform sleep health, breathing health, and healthcare technology at home. By building on our leadership in connected digital health, we are driving better care, simplifying the health journey, and improving access to our therapies globally so even more people worldwide are empowered to live healthier, higher-quality lives using products and services they love."

User Image 1986iamwallstreet Posted - 10/24/24

$RMD sell

User Image RockyTSTH Posted - 10/24/24

$RMD ResMed Q1 2025 Adj. EPS $2.20 Beats $2.04 Estimate, Sales $1.224B Beat $1.180B Estimate

User Image howardlindzon Posted - 10/24/24

$RMD

User Image DonCorleone77 Posted - 10/24/24

$RMD ResMed options imply 6.9% move in share price post-earnings Pre-earnings options volume in ResMed is 3.5x normal with puts leading calls 7:5. Implied volatility suggests the market is anticipating a move near 6.9%, or $16.63, after results are released. Median move over the past eight quarters is 6.4%.

User Image RockyTSTH Posted - 10/24/24

$RMD - stock seeing put flow on the rise but has one big longer dated call flow coming in pre earnings. Market expects a 9% move on earnings.

User Image Himel92 Posted - 10/22/24

The Last month Performance for $RMD Opening Price: $245.00 Closing Price: $240.05 Highest Price: $249.40 Lowest Price: $230.44 Percentage Change: -2.02% Data provider: AITX

User Image Wallywally123 Posted - 1 month ago

$RMD Just thinking out loud here. The new iPhone has an new app for sleep apnea. Why? I believe that this will help sales for Resmed in the future. Question time: Why did Apple develop an app for sleep apnea as it cost and development would have cost a fortune ? Could Apple be looking to take over Resmed? Resmed has a profitable IT technology department and it fit perfectly into Apple's portfolio Sales could increase dramatically if this app is widely used and properly analysed by professionals medical staff? *The FDA has approved Apple's sleep apnea detection feature. *Sleep apnea is a sleep disorder that causes a person's breathing to repeatedly stop and start throughout the night. *The feature is designed for the Apple Watch, and it works by analyzing a new metric that the company calls "breathing disturbances Steve from Australia

User Image insiderbuyingselling Posted - 1 month ago

$RMD new insider selling: 4260 shares. http://insiderbuyingselling.com/?t=RMD

Analyst Ratings
RBC Capital Sector Perform Oct 1, 24
Needham Hold Oct 1, 24
B of A Securities Buy Sep 26, 24
Baird Outperform Sep 24, 24
Needham Hold Sep 18, 24
Wolfe Research Underperform Sep 18, 24
Needham Hold Sep 4, 24
RBC Capital Sector Perform Aug 2, 24
Keybanc Overweight Aug 2, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sandercock Brett Chief Financial Offi.. Chief Financial Officer Nov 27 Sell 152.6201 3,000 457,860 92,962 11/29/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Nov 16 Option 57.76 3,462 199,965 444,448 11/20/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Nov 15 Sell 152.04 5,678 863,283 440,986 11/16/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Nov 15 Option 57.76 5,678 327,961 446,664 11/16/23
Rider Michael J Global General Couns.. Global General Counsel Nov 01 Sell 143.42 25 3,585 7,358 11/02/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Oct 16 Sell 140.7 5,675 798,472 449,360 10/17/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Oct 16 Option 57.76 5,675 327,788 455,035 10/17/23
Rider Michael J Global General Couns.. Global General Counsel Oct 02 Sell 145.92 25 3,648 7,383 10/04/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Sep 15 Sell 146.35 5,675 830,536 449,360 09/19/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Sep 15 Option 57.76 5,675 327,788 455,035 09/19/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Aug 15 Sell 183.2 5,675 1,039,660 436,930 08/17/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Aug 15 Option 57.76 5,675 327,788 442,605 08/17/23
Douglas Robert Andrew President and COO President and COO Aug 15 Sell 181.01 1,500 271,515 250,526 08/16/23
Rider Michael J Global General Couns.. Global General Counsel Aug 01 Sell 224.12 25 5,603 5,186 08/02/23
Ghoshal Kaushik President, SaaS Busi.. President, SaaS Business Jul 13 Sell 220.00 500 110,000 11,787 07/14/23
Douglas Robert Andrew President and COO President and COO May 15 Sell 232.85 1,500 349,275 255,026 05/16/23
Sandercock Brett Chief Financial Offi.. Chief Financial Officer May 10 Sell 233.1315 12,574 2,931,395 90,942 05/12/23
Sandercock Brett Chief Financial Offi.. Chief Financial Officer May 09 Sell 232.049 3,426 795,000 103,516 05/10/23
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer May 03 Sell 237.64 1,500 356,460 91,172 05/04/23
Ghoshal Kaushik President, SaaS Busi.. President, SaaS Business May 01 Sell 239.30 500 119,650 12,704 05/02/23
Ghoshal Kaushik President, SaaS Busi.. President, SaaS Business Apr 24 Sell 230.00 2,000 460,000 13,204 04/25/23
Douglas Robert Andrew President and COO President and COO Apr 17 Sell 224.65 1,500 336,975 256,526 04/18/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Apr 17 Sell 224.23 5,675 1,272,505 436,900 04/18/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Apr 17 Option 57.76 5,675 327,788 442,575 04/18/23
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Mar 03 Sell 216.69 1,500 325,035 94,172 03/07/23
Ghoshal Kaushik President, SaaS Busi.. President, SaaS Business Mar 03 Sell 220.00 1,000 220,000 15,704 03/07/23
Douglas Robert Andrew President and COO President and COO Feb 15 Sell 213.50 1,500 320,250 261,445 02/16/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Feb 15 Sell 214.83 5,675 1,219,160 436,900 02/16/23
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Feb 15 Option 57.76 5,675 327,788 442,575 02/16/23
Sandercock Brett Chief Financial Offi.. Chief Financial Officer Feb 13 Sell 215.00 4,000 860,000 116,880 02/14/23
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Feb 03 Sell 224.50 1,500 336,750 95,672 02/06/23
Drexler Karen Director Director Feb 02 Sell 226.58 594 134,589 7,987 02/03/23
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Jan 03 Sell 210.07 1,500 315,105 97,172 01/05/23
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Dec 05 Sell 229.81 1,500 344,715 98,672 12/06/22
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Nov 25 Option 146.34 683 99,950 107,472 11/29/22
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Nov 15 Option 57.76 5,675 327,788 419,699 11/16/22
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Nov 15 Sell 224.64 5,675 1,274,832 414,024 11/16/22
Sandercock Brett Chief Financial Offi.. Chief Financial Officer Nov 07 Sell 212.0169 4,000 848,068 106,303 11/09/22
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Nov 03 Sell 215.23 1,545 332,530 102,334 11/04/22
Douglas Robert Andrew President and COO President and COO Oct 14 Option 58.24 18,033 1,050,242 46,441 10/17/22
Douglas Robert Andrew President and COO President and COO Oct 14 Sell 215.09 11,355 2,442,347 35,086 10/17/22
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Oct 03 Sell 220.19 1,545 340,194 103,879 10/05/22
Douglas Robert Andrew President and COO President and COO Sep 15 Option 58.24 18,033 1,050,242 39,597 09/16/22
Douglas Robert Andrew President and COO President and COO Sep 15 Sell 232.45 17,189 3,995,583 228,995 09/16/22
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Sep 06 Sell 216.92 1,545 335,141 105,424 09/07/22
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Aug 15 Option 57.76 5,675 327,788 410,935 08/17/22
Farrell Michael J. Chief Executive Offi.. Chief Executive Officer Aug 15 Sell 238.09 5,675 1,351,161 405,260 08/17/22
Sandercock Brett Chief Financial Offi.. Chief Financial Officer Aug 10 Option 57.76 2,500 144,400 108,926 08/12/22
Sandercock Brett Chief Financial Offi.. Chief Financial Officer Aug 10 Sell 240.66 2,500 601,650 106,426 08/12/22
PENDARVIS DAVID Chief Administrative.. Chief Administrative Officer Aug 03 Sell 240.72 1,545 371,912 105,286 08/04/22